
In May 2025, Occam Global, a leading biotech executive recruiting firm, placed Angus Sinclair, PhD, as Chief Scientific Officer at London-based LabGenius Therapeutics.
As CSO, Sinclair will leverage his extensive experience in drug discovery to lead LabGenius’ scientific strategy, driving innovation in both pipeline and platforms. Angus joins LabGenius from IGM Biosciences, where he was EVP, Research, overseeing the advancement of over 15 novel, potent antibody-based therapeutics from concept through preclinical development, resulting in multiple IND filings. Prior, Angus was Senior Director of Oncology Research at Northern Biologics, leading the validation of novel oncology targets. He also held several senior positions at Amgen during his 13-year tenure, including Scientific Director ofOncology Research.
Angus received his undergraduate degree in Molecular Biology from The University of Edinburgh and his PhD in Hematology/Molecular Biology from University College London.
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.